Emergence of Klebsiella pneumoniae carbapenemase-producing Escherichia coli sequence type 131 in Hangzhou, China

Chinese Medical Journal

Volumn 127, Issue 3, 2014, Pages 528-531

  Lou, Zheng Qing ^a   Qi, Yan ^a   Qian, Xiang ^a   Yang, Wei ^a   Wei, Ze Qing ^b  

^a Hangzhou Hospital of Traditional Chinese Medicine   (China)

^b ZHEJIANG UNIVERSITY   (China)

Author keywords

Escherichia coli; Klebsiella pneumoniae carbapenemase; Sequence type

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; BETA LACTAMASE; CARBAPENEMASE; CEFEPIME; CEFOPERAZONE PLUS SULBACTAM; EXTENDED SPECTRUM BETA LACTAMASE; IMIPENEM; MEROPENEM; PIPERACILLIN PLUS TAZOBACTAM; BACTERIAL PROTEIN;

ANTIBIOTIC SENSITIVITY; ARTICLE; CASE REPORT; CHINA; ESCHERICHIA COLI; HUMAN; KLEBSIELLA PNEUMONIAE; MOLECULAR EPIDEMIOLOGY; MULTILOCUS SEQUENCE TYPING; PULSED FIELD GEL ELECTROPHORESIS; SPECIES IDENTIFICATION; ENZYMOLOGY; GENETICS;

BACTERIAL PROTEINS; BETA-LACTAMASES; CHINA; ELECTROPHORESIS, GEL, PULSED-FIELD; ESCHERICHIA COLI; KLEBSIELLA PNEUMONIAE; MULTILOCUS SEQUENCE TYPING;

EID: 84893058599     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.20130253     Document Type: Article

References (22)

1. Yigit H, Queenan AM, Anderson GJ, Domenech-Sanchez A, Biddle JW, Steward CD, et al. Novel carbapenem-hydrolyzing β-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae. Antimicrob Agents Chemother 2001; 45: 1151-1161.
2. Naas T, Nordmann P, Vedel G, Poyart C. Plasmid-mediated carbapenem-hydrolyzing β-lactamase KPC in a Klebsiella pneumoniae isolate from France. Antimicrob Agents Chemother 2005; 49: 4423-4424.
3. Wei ZQ, Du XX, Yu YS, Shen P, Chen YG, Li LJ. Plasmid-Mediated KPC-2 in a Klebsiella pneumoniae isolate from China. Antimicrob Agents Chemother 2007; 51: 763-765.
4. Cuzon G, Naas T, Demachy MC, Nordmann P. Plasmidmediated carbapenem-hydrolyzing β-lactamase KPC-2 in Klebsiella pneumoniae isolate from Greece. Antimicrob Agents Chemother 2008; 52: 796-797.
5. Chmelnitsky I, Hermesh O, Navon-Venezia S, Strahilevitz J, Carmeli Y. Detection of aac(6́)-Ib-cr in KPC-producing Klebsiella pneumoniae isolates from Tel Aviv, Israel. J Antimicrob Chemother 2009; 64: 718-722.
6. Wendt C, Schütt S, Dalpke AH, Konrad M, Mieth M, Trierweiler-Hauke B, et al. First outbreak of Klebsiella pneumoniae carbapenemase (KPC)-producing K. pneumoniae in Germany. Eur J Clin Microbiol Infect Dis 2010; 29: 563-570.
7. Cai JC, Zhou HW, Zhang R, Chen GX. Emergence of Serratia marcescens, Klebsiella pneumoniae, and Escherichia coli isolates possessing the plasmid-mediated carbapenemhydrolyzing β-lactamase KPC-2 in intensive care units of a Chinese hospital. Antimicrob Agents Chemother 2008; 52: 2014-2018.
8. Naas T, Cuzon G, Gaillot O, Courcol R, Nordmann P. When carbapenem hydrolyzing β-lactamase KPC meets Escherichia coli ST131 in France. Antimicrob Agents Chemother 2011; 55: 4933-4934.
9. Morris D, Boyle F, Ludden C, Condon I, Hale J, O'Connell N, et al. Production of KPC-2 carbapenemase by an Escherichia coli clinical isolate belonging to the international ST131 clone. Antimicrob Agents Chemother 2011; 55: 4935-4936.
10. Mavroidi A, Miriagou V, Malli E, Stefos A, Dalekos GN, Tzouvelekis LS, et al. Emergence of Escherichia coli sequence type 410 (ST410) with KPC-2 β-lactamase. Int J Antimicrob Agents 2012; 39: 247-250.
11. CLSI. Performance Standards for Antimicrobial Susceptibility Testing; Twenty-second Informational Supplement. CLSI document M100-S22. Wayne, PA: Clinical and Laboratory Standards Institute; 2012.
12. Liu Y, Zhang B, Cao Q, Huang W, Shen L, Qin X. Two clinical strains of Klebsiella pneumoniae carrying plasmid-borne blaIMP-4, blaSHV-12, and armA isolated at a Pediatric Center in Shanghai, China. Antimicrob Agents Chemother 2009; 53: 1642-1644.
13. Pérez-Pérez FJ, Hanson ND. Detection of plasmid-mediated AmpC β-lactamase genes in clinical isolates by using multiplex PCR. J Clin Microbiol 2002; 40: 2153-2162.
14. Shen P, Wei Z, Jiang Y, Du X, Ji S, Yu Y, et al. Novel Genetic Environment of the Carbapenem-Hydrolyzing β-Lactamase KPC-2 among Enterobacteriaceae in China. Antimicrob Agents Chemother 2009; 10: 4333-4338.
15. Yu Y, Ji S, Chen Y, Zhou W, Wei Z, Li L, et al. Resistance of strains producing extended-spectrum beta-lactamases and genotype distribution in China. J Infect 2007; 54: 53-57.
16. Gouby A, Neuwirth C, Bourg G, Bouziges N, Carles-Nurit MJ, Despaux E, et al. Epidemiological study by pulsed-field gel electrophoresis of an outbreak of extended-spectrum betalactamase producing Klebsiella pneumoniae in a geriatric hospital. J Clin Microbiol 1994; 32: 301-305.
17. Tenover FC, Arbeit RD, Goering RV, Mickelsen PA, Murray BE, Persing DH, et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 1995; 33: 2233-2239.
18. Barton BM, Harding GP, Zuccarelli AJ. A general method for detecting and sizing large plasmids. Anal Biochem 1995; 226: 235-240.
19. Qi Y, Wei Z, Ji S, Du X, Shen P, Yu Y. ST11, the dominant clone of KPC-producing Klebsiella pneumoniae in China. J Antimicrob Chemother 2011; 66: 307-312.
20. Rogers BA, Sidjabat HE, Paterson DL. Escherichia coli O25b-ST131: a pandemic, multiresistant, community-associated strain. J Antimicrob Chemother 2011; 66: 1-14.
21. Novais A, Pires J, Ferreira H, Costa L, Montenegro C, Vuotto C, et al. Characterization of Globally Spread Escherichia coli ST131 Isolates (1991 to 2010). Antimicrob Agents Chemother 2012; 56: 3973-3976.
22. Matsumura Y, Yamamoto M, Nagao M, Hotta G, Matsushima A, Ito Y, et al. Emergence and spread of B2-ST131-O25b, B2-ST131-O16 and D-ST405 clonal groups among extendedspectrum-β-lactamase-producing Escherichia coli in Japan. J Antimicrob Chemother 2012; 67: 2612-2620.